XAIR - Beyond Air, Inc.

0.5153
-0.030   -5.764%

Share volume: 514,595
Last Updated: 04-21-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$0.54
-0.03
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 33%
Dept financing 19%
Liquidity 40%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.28%
1 Month
-36.21%
3 Months
-70.89%
6 Months
-74.24%
1 Year
124.14%
2 Year
-57.41%
Key data
Stock price
$0.52
P/E Ratio 
0.00
DAY RANGE
$0.51 - $0.58
EPS 
-$3.78
52 WEEK RANGE
$0.15 - $4.78
52 WEEK CHANGE
$148.82
MARKET CAP 
5.815 M
YIELD 
N/A
SHARES OUTSTANDING 
10.529 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-23-2025
BETA 
1.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$935,300
AVERAGE 30 VOLUME 
$437,081
Company detail
CEO: Steven A. Lisi
Region: US
Website: beyondair.net
Employees: 70
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Beyond Air, Inc. develops nitric oxide generator and delivery systems. LungFit system is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors.

Recent news